Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

Posted By Global Banking and Finance Review

Posted on January 23, 2025

Essity could move more production into US if tariffs are introduced, CEO says

By Agata Rybska

(Reuters) - Swedish hygiene product and tissue maker Essity could move more of its production into the U.S. from Mexico and Canada if tariffs are introduced by President Donald Trump, but is not considering plant closures, CEO Magnus Groth said on Thursday.

Essity generates some 14% of its sales in the U.S. and 10% of the products sold there are imported, mainly from Mexico and Canada, Groth told Reuters in an interview.

"We're looking at ways, if needed, to move production even more into the U.S.," he said.

Groth said, however, that the plants in Canada and Mexico would not be impacted by U.S. production becoming more local, as they would still cater to local needs.

Essity has one tissue plant in Drummondville, Canada, and five production facilities for tissue, personal care and medical solutions in Mexico, located in Ecatepec, Monterrey, Reynosa, Sahagun and Uruapan. Three of the Mexican plants produce tissue paper, according to its latest sustainability report for 2023.

It has eight production facilities in the U.S., operating in the same business areas as the Mexican ones, a company spokesperson said.

Essity employs 404 people in Canada, 3,800 in Mexico and 3,200 in the United States.

(Reporting by Agata Rybska in Gdansk; editing by Milla Nissi)

Recommended for you

  • UK's Reeves says will announce new fiscal measures March 26, if needed

  • Ukraine's Ukrnafta increased oil output by 0.6% in 2024, says CEO

  • Irish foreign direct investment chief plays down Trump tax move, Irish Times reports